Comparison of 0.12% Chlorhexidine and MicroRepair ABX Mouthwash in Gingivitis Management

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

March 10, 2026

Conditions
GingivitisDental PlaqueGingival Inflammation
Interventions
DRUG

MicroRepair ABX mouthwash

Participants begin at T0 (baseline) with clinical assessments, oral hygiene instruction, and the start of a 14-day home regimen using MicroRepair® ABX mouthwash. The formulation contains zinc-hydroxyapatite with antibacterial agents (cetylpyridinium chloride, magnolol, honokiol). Mouthwash is used twice daily (10 mL for 30 seconds) without rinsing, and participants avoid food or drink for 1 hour afterward. All participants use the same sodium lauryl sulfate (SLS)-free toothpaste (Biorepair®) throughout the study.

DRUG

Chlorhexidine 0.12% mouthwash

Participants begin at T0 (baseline) with clinical assessments, oral hygiene instruction, and the start of a 14-day home regimen using 0.12% chlorhexidine (CHX) mouthwash. Mouthwash is used twice daily (10 mL for 30 seconds) without rinsing, and participants avoid food or drink for 1 hour afterward. All participants use the same SLS-free toothpaste (Biorepair®) throughout the study.

Trial Locations (1)

27100

RECRUITING

Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia, Pavia

All Listed Sponsors
lead

University of Pavia

OTHER

NCT07088653 - Comparison of 0.12% Chlorhexidine and MicroRepair ABX Mouthwash in Gingivitis Management | Biotech Hunter | Biotech Hunter